Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalworth Regulatory News (GWI)

Share Price Information for Globalworth (GWI)

Share Price is delayed by 15 minutes
Get Live Data
1.70    0.00 (0.00%)
Bid:
1.69
Ask:
1.70
Spread: 0.01 (0.592%)
Market Cap: €511.08m
GWI Live PriceLast checked at - London Stock Exchange

Intraday Globalworth Share Chart

Form 8.5 (EPT/RI)

26 May 2021 08:48

RNS Number : 8649Z
Citigroup Global Markets Limited
26 May 2021
 

 

 

 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH

RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Citigroup Global Markets Limited

(b) Name of offeror/offeree in relation to whoserelevant securities this form relates:Use a separate form for each offeror/offeree

Globalworth Real Estate Investments Limited

(c) Name of the party to the offer with which exemptprincipal trader is connected:

Globalworth Real Estate Investments Limited

(d) Date dealing undertaken:

25 May 2021

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received(EUR)

Lowest price per unit paid/received(EUR)

Ordinary

Purchase

101

7.1200

7.1200

Ordinary

Sale

101

7.1200

7.1200

 

(b) Cash-settled derivative transactions

 

 

Class of relevant security

Product description e.g. CFD

Nature of dealinge.g. opening/closing along/short position,increasing/reducing along/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing,selling,varying etc.

Number of securities towhich option relates

Exercise price per unit

Type e.g. American,European etc.

Expiry date

Option money paid/ received per unit

 

 

(ii) Exercise

 

 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number ofsecurities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

 

Class of relevant security

Nature of dealinge.g. subscription, conversion

Details

Price per unit(if applicable)

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,formal or informal, relating to relevant securities which may be an inducement to dealor refrain from dealing entered into by the exempt principal trader making thedisclosure and any party to the offer or any person acting in concert witha party to the offer:

 

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, betweenthe exempt principal trader making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

 

If there are no such agreements, arrangements or understandings, state "none"

None

 

Date of disclosure:

26 May 2021

Contact name:

Cathal McKenna

Telephone number:

02890 409 544

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory InformationService and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERDZGZKNVNGMZG
Date   Source Headline
22nd Dec 20147:00 amRNSAcquisition of Unicredit Headquarters Building
19th Dec 20145:10 pmRNSStatement re Romanian Press
19th Dec 20144:23 pmRNSAdditional Listing
8th Dec 20147:00 amRNSAcquisition of Nusco Tower
5th Dec 20147:00 amRNSSigning of new lease agreement at TAP
27th Nov 20147:00 amRNSAcquisition of Green Court
21st Nov 20147:00 amRNSSigning of landmark lease agreement
17th Nov 20147:00 amRNSQ3 Trading Update and EPRA NAV
31st Oct 20147:00 amRNSClosing of EUR 30 million debt financing facility
30th Sep 20147:00 amRNSAppointment of New Non-Executive Directors
25th Sep 20147:00 amRNSHalf Yearly Report
5th Aug 20141:56 pmRNSAcquisition of TAP
30th Jul 20149:30 amRNS1st Quarter Results
8th Jul 20144:03 pmRNSName change of Administrator and Company Secretary
20th Jun 20147:00 amRNSAcquisition of Land Plots in Bucharest
19th Jun 20142:33 pmRNSResult of AGM
15th May 20144:00 pmRNSPosting of Annual Report and Notice of AGM
29th Apr 201411:15 amRNSHolding(s) in Company
29th Apr 201411:15 amRNSHolding(s) in Company
23rd Apr 20144:30 pmRNSCompletion of Fundraising
11th Apr 20142:30 pmRNSPassing of Written Resolution
25th Mar 20147:05 amRNSShare Issue
25th Mar 20147:00 amRNSProposed Placing of Ordinary Shares
24th Mar 20147:05 amRNSTrading and Market Update
24th Mar 20147:00 amRNSUnaudited pro forma consolidated 2013 financials
20th Mar 20144:57 pmRNSAcquisition of Upground Towers
19th Feb 20147:00 amRNSAcquisition of Tower Center International
14th Feb 20147:00 amRNSBank facility signed with UBS
12th Feb 20147:00 amRNSFinal Results
31st Jan 20147:00 amRNSContractor appointed for Bucharest One
29th Jan 20147:00 amRNSAppointment of CFO
27th Dec 20137:01 amRNSChange of Registered Office
27th Dec 20137:00 amRNSAcquisition of Bucharest One
16th Dec 20137:00 amRNSAcquisition
5th Dec 20137:00 amRNSDirectorate Change
30th Sep 20137:00 amRNSCompletion of first acquisition
27th Sep 20137:00 amRNSUnaudited interim results to 30 June 2013
11th Sep 20134:16 pmRNSUpdate on Anticipated Acquisition of Tower Center
14th Aug 201311:50 amRNSTR-1: Notification of Major Interest in Shares
7th Aug 20134:00 pmRNSSignificant Shareholding
1st Aug 20133:49 pmRNSDirector/PDMR Shareholding
1st Aug 20133:47 pmRNSSignificant Shareholding
25th Jul 20137:00 amRNSCompletion of IPO and Admission to trading on AIM
21st Jan 20087:00 amPRNRe Agreement
14th Jan 20087:00 amPRNCommissioning of Manazil's New Production Facility
27th Nov 20074:42 pmPRNStatement re New Production Facility in Tehran
8th Nov 20077:00 amPRN3rd Quarter Results
29th Oct 20072:50 pmPRNStatement re Genesis Appointment for KML Building
22nd Oct 20074:42 pmPRNStatement re Third quarter results release date
4th Oct 20074:36 pmPRNCommissioning of Production Facility

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.